ScholarIQanswers from OpenAlex

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer

PaperCitations, authors & open-access status

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer have?

ScholarIQcitation count

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has 72 citations in the OpenAlex counts ScholarIQ stores.

When was LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer published?

ScholarIQyear

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has 2018 year in the ScholarIQ index.

What is the open-access status of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

ScholarIQoa status

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer has green oa status in the ScholarIQ index.

What is the DOI of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

ScholarIQdoi

The DOI for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

What is the PMID of LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

ScholarIQpmid

The PMID for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

What is the OpenAlex record for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer?

ScholarIQopenalex

The OpenAlex for LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial